Found: 151
Select item for more details and to access through your institution.
Twelve-month resistance and impact exercise program or risedronate provides a relative benefit to hip bone structure in postmenopausal women: results from a randomized controlled trial.
- Published in:
- Osteoporosis International, 2024, v. 35, n. 5, p. 877, doi. 10.1007/s00198-023-07008-x
- By:
- Publication type:
- Article
Can locally applied risedronate be an effective agent when combined with xenografts? An animal study.
- Published in:
- BMC Oral Health, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12903-023-03231-4
- By:
- Publication type:
- Article
Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 5, p. 977, doi. 10.1007/s00198-022-06627-0
- By:
- Publication type:
- Article
Bone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 3, p. 573, doi. 10.1007/s00198-022-06648-9
- By:
- Publication type:
- Article
Effects of a locally administered risedronate/autogenous bone graft combination on bone healing in a critical-size rabbit defect model.
- Published in:
- Journal of Orthopaedic Surgery & Research, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13018-023-03568-0
- By:
- Publication type:
- Article
Review of bone health in women with estrogen receptor–positive breast cancer receiving endocrine therapy.
- Published in:
- Women's Health (17455057), 2023, p. 1, doi. 10.1177/17455057221149493
- By:
- Publication type:
- Article
Bone Health and Denosumab Discontinuation in Oncology Populations.
- Published in:
- Oncologist, 2022, v. 27, n. 12, p. 998, doi. 10.1093/oncolo/oyac213
- By:
- Publication type:
- Article
Correction to: The clinician's guide to prevention and treatment of osteoporosis.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Cardiovascular Safety and Effectiveness of Bisphosphonates: From Intervention Trials to Real-Life Data.
- Published in:
- Nutrients, 2022, v. 14, n. 12, p. 2369, doi. 10.3390/nu14122369
- By:
- Publication type:
- Article
Comment on "The efficiency of risedronate in reducing bone resorption after total hip arthroplasty: a meta-analysis of randomized control trials at a minimum of 6 months' follow-up".
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Bone-loading exercises versus risedronate for the prevention of osteoporosis in postmenopausal women with low bone mass: a randomized controlled trial.
- Published in:
- Osteoporosis International, 2022, v. 33, n. 2, p. 475, doi. 10.1007/s00198-021-06083-2
- By:
- Publication type:
- Article
Letter to the Editor: Oral risedronate increases Gruen zone bone mineral density after primary total hip arthroplasty: a meta-analysis.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Fracture rates and economic outcomes in patients with osteoporosis prescribed risedronate gastro-resistant versus other oral bisphosphonates: a claims data analysis.
- Published in:
- Osteoporosis International, 2022, v. 33, n. 1, p. 217, doi. 10.1007/s00198-021-06108-w
- By:
- Publication type:
- Article
Osteoporosis treatment with risedronate: a population pharmacokinetic model for the description of its absorption and low plasma levels.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 11, p. 2313, doi. 10.1007/s00198-021-05944-0
- By:
- Publication type:
- Article
The Effect of Antiosteoporosis Therapy With Risedronate on Rotator Cuff Healing in an Osteoporotic Rat Model.
- Published in:
- American Journal of Sports Medicine, 2021, v. 49, n. 8, p. 2074, doi. 10.1177/03635465211011748
- By:
- Publication type:
- Article
Over half of seniors who start oral bisphosphonate therapy are exposed for 3 or more years: novel rolling window approach and patterns of use.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 7, p. 1413, doi. 10.1007/s00198-020-05794-2
- By:
- Publication type:
- Article
Efficacy and safety of sodium RISedronate for glucocorticoid-induced OsTeoporosis with rheumaTOid arthritis (RISOTTO study): A multicentre, double-blind, randomized, placebo-controlled trial.
- Published in:
- Modern Rheumatology, 2021, v. 31, n. 3, p. 593, doi. 10.1080/14397595.2020.1812835
- By:
- Publication type:
- Article
Histomorphometric Effects of 2% Risedronate Gel on Calvarial Bone Defects in Rabbits.
- Published in:
- Journal of Dentistry (2345-6485), 2021, v. 22, n. 1, p. 14, doi. 10.30476/DENTJODS.2020.82926.1032
- By:
- Publication type:
- Article
Upper gastrointestinal safety of oral bisphosphonate in hospitalized patients.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 1, p. 193, doi. 10.1007/s00198-020-05498-7
- By:
- Publication type:
- Article
Journal of Bone and Mineral Metabolism Best Paper Award 2020.
- Published in:
- Journal of Bone & Mineral Metabolism, 2020, v. 38, n. 6, p. 745, doi. 10.1007/s00774-020-01166-2
- Publication type:
- Article
Efficacy of teriparatide compared with risedronate on FRAX<sup>®</sup>-defined major osteoporotic fractures: results of the VERO clinical trial.
- Published in:
- Osteoporosis International, 2020, v. 31, n. 10, p. 1935, doi. 10.1007/s00198-020-05463-4
- By:
- Publication type:
- Article
Skeletal and mineral metabolic effects of risedronate in a rat model of high-turnover renal osteodystrophy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Biomaterials Development, Modification, and Potential Application for Interventional Cardiology.
- Published in:
- BioMed Research International, 2020, p. 1, doi. 10.1155/2020/4890483
- By:
- Publication type:
- Article
Phase II/III, randomized, double-blind, parallel-group study of monthly delayed-release versus daily immediate-release risedronate tablets in Japanese patients with involutional osteoporosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Risedronate Effects on the In Vivo Bioactive Glass Behavior: Nuclear Magnetic Resonance and Histopathological Studies.
- Published in:
- BioMed Research International, 2019, p. 1, doi. 10.1155/2019/2175731
- By:
- Publication type:
- Article
Safety and efficacy of risedronate for patients with esophageal varices and liver cirrhosis: a non-randomized clinical trial.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-55603-y
- By:
- Publication type:
- Article
Bisphosphonates and lower mortality risk: when it sounds to be good to be true ...
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Bisphosphonate drug holidays.
- Published in:
- Osteoporosis International, 2019, v. 30, n. 12, p. 2525, doi. 10.1007/s00198-019-05107-2
- By:
- Publication type:
- Article
Bisphosphonates for Secondary Prevention of Osteoporotic Fractures: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.
- Published in:
- BioMed Research International, 2019, p. 1, doi. 10.1155/2019/2594149
- By:
- Publication type:
- Article
Time trends in oral bisphosphonate initiation in Ontario, Canada over 20 years reflect drug policy and healthcare delivery changes.
- Published in:
- Osteoporosis International, 2019, v. 30, n. 11, p. 2311, doi. 10.1007/s00198-019-05061-z
- By:
- Publication type:
- Article
Where Does Denosumab Stand in the Treatment of Glucocorticoid‐Induced Osteoporosis? Comment on the Article by Saag et al.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Reply.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Efficacy and safety of once-monthly risedronate in osteoporosis subjects with mild-to-moderate chronic kidney disease: a post hoc subgroup analysis of a phase III trial in Japan.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France.
- Published in:
- Osteoporosis International, 2019, v. 30, n. 3, p. 649, doi. 10.1007/s00198-018-04821-7
- By:
- Publication type:
- Article
Comparison of the efficacy between once-monthly oral ibandronate and risedronate among Korean women with osteoporosis: a nationwide population-based study.
- Published in:
- Osteoporosis International, 2019, v. 30, n. 3, p. 659, doi. 10.1007/s00198-018-4778-0
- By:
- Publication type:
- Article
Factors associated with inadequate responses to risedronate in Japanese patients with osteoporosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Risedronate extraction from artificial urine with using monolithic polymer-based anion exchangers.
- Published in:
- Journal of the Iranian Chemical Society, 2019, v. 16, n. 1, p. 93, doi. 10.1007/s13738-018-1484-y
- By:
- Publication type:
- Article
How to use bisphosphonates safely and optimally.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
The kinetic study of the thermally induced degradation and an evaluation of the drug-excipient interactions performed for a new-generation bisphosphonate—risedronate.
- Published in:
- Journal of Thermal Analysis & Calorimetry, 2018, v. 134, n. 1, p. 721, doi. 10.1007/s10973-018-7216-9
- By:
- Publication type:
- Article
Efficacy of discontinuing risedronate for patients with systemic lupus erythematosus: a prospective study.
- Published in:
- Lupus, 2018, v. 27, n. 10, p. 1636, doi. 10.1177/0961203318784649
- By:
- Publication type:
- Article
Effects of once-monthly minodronate versus risedronate in osteoporosis patients with rheumatoid arthritis: a 12-month randomized head-to-head comparison.
- Published in:
- Osteoporosis International, 2018, v. 29, n. 7, p. 1637, doi. 10.1007/s00198-018-4494-9
- By:
- Publication type:
- Article
Oral risedronate increases Gruen zone bone mineral density after primary total hip arthroplasty: a meta-analysis.
- Published in:
- Journal of Orthopaedic Surgery & Research, 2018, v. 13, n. 1, p. N.PAG, doi. 10.1186/s13018-018-0794-1
- By:
- Publication type:
- Article
Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density.
- Published in:
- Osteoporosis International, 2018, v. 29, n. 6, p. 1407, doi. 10.1007/s00198-018-4460-6
- By:
- Publication type:
- Article
The efficiency of risedronate in reducing bone resorption after total hip arthroplasty: a meta-analysis of randomized control trials at a minimum of 6 months' follow-up.
- Published in:
- Journal of Orthopaedic Surgery & Research, 2018, v. 13, n. 1, p. N.PAG, doi. 10.1186/s13018-018-0808-z
- By:
- Publication type:
- Article
Treatment of Low BMD and Osteoporosis to Prevent Fractures: Updated Guideline from the ACP.
- Published in:
- 2018
- By:
- Publication type:
- journal article
运动联合利塞膦酸钠治疗绝经后女性骨质疏松症疗效分析.
- Published in:
- Chinese Journal of Osteoporosis, 2018, v. 24, n. 3, p. 315, doi. 10.3969/j.issn.1006-7108.2018.03.007
- By:
- Publication type:
- Article
Pregnancy-Associated Osteoporosis: Long-term Follow-up of a Patient with Two Pregnancies.
- Published in:
- Turkish Journal of Endocrinology & Metabolism, 2018, v. 22, n. 1, p. 50, doi. 10.25179/tjem.2017-56508
- By:
- Publication type:
- Article
利塞膦酸钠联合PFNA 治疗老年股骨粗隆间骨折的随机对照研究.
- Published in:
- Practical Pharmacy & Clinical Remedies, 2018, v. 21, n. 1, p. 55, doi. 10.14053/j.cnki.ppcr.201801014
- By:
- Publication type:
- Article
Protective effect of low-dose risedronate against osteocyte apoptosis and bone loss in ovariectomized rats.
- Published in:
- PLoS ONE, 2017, v. 12, n. 10, p. 1, doi. 10.1371/journal.pone.0186012
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- Fundamental & Clinical Pharmacology, 2017, v. 31, n. 5, p. 590, doi. 10.1111/fcp.12305
- Publication type:
- Article